Skip to content

Douglas Pharmaceuticals

Just another WordPress site

Month: October 2022

Clinicians China licenced to HTDK Pharmaceuticals

Published 3 October 2022

Categorized as Commercial

Search

Recent Posts

Douglas People & Culture team win HR Team of the Year
Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia
Formation of Clinical Advisory Board for Lead Program R-107
Clinicians China licenced to HTDK Pharmaceuticals
New Zealand’s largest medical R&D facility opens in West Auckland

Recent Comments

No comments to show.

Archives

November 2023
September 2023
February 2023
October 2022
September 2022
June 2021
April 2020
November 2019
May 2019
April 2019
January 2019
December 2018
November 2018

Categories

Awards
Commercial
Corporate Responsibility
Large Dispensers
Research

Douglas Pharmaceuticals

Proudly powered by WordPress.